|
Kravchenko A.V., Shimonova I.E., Ulyanova Y.S., Kuznetsova A.V, Isaeva G.N., Sizova N.V., Palaguta A.E., Baburina A.R., Shevchenko V.V., Ulchiekova M.A., Fisenko E.G., Radzikhovskaya M.V., Musatov V.B., Anoprienko E.A., Malyugina N.E., Pokrovskaya A.V., Zhuravkova O.L., Elistratova O.V., Volova L.Yu., Ushakova A.A., Lomakina E.A., Laseeva M.G., Terekhova M.V.
Results of post-registration study of efficacy and safety of antiretroviral therapy schemes including elsulfavirine in previously non-treated HIV-infected patients (PASS-1)
|
№3 / 2024
|
|
Pokrovskaya A.V., Kirichenko A.A., Khokhlova O.N., Kulabukhova E.I., Goliusova M.D., Kireev D.E., Yurin O.G.
Dynamics of HIV reservoirs during the use of a two-component regimen with dolutegravir and lamivudine in HIV-infected patients who have not previously received treatment
|
№3 / 2024
|
|
Koshkin A.M., Pokrovskaya A.V.
Two-drug antiretroviral therapy regimen with dolutegravir and lamivudine for previously untreated HIV-infected patients
|
№3 / 2023
|
|
Sokolova E.V., Ladnaia N.N., Pokrovsky V.V., Kravchenko A.V., Kozyrina N.V., Yurin O.G., Chekryzhova D.G.
Impact of antiretroviral therapy on the development of the HIV-infection epidemic in the Russian Federation
|
№3 / 2023
|
|
Pokrovsky V.V.
Human immunodeficiency virus and death
|
№3 / 2023
|
|
Kozyrina N.V., Belyaeva V.V., Sokolova E.V., Semikova S.Yu., Lebedeva E.P., Gavrilova O.V., Galiullin N.I., Beshimov A.T., Khoraskina E.A., Narkevich A.N., Suvorova Z.K., Khokhlova O.N.
The place of antiretroviral therapy in the behavioral strategies aimed at maintaining the health and quality of counseling of people living with HIV
|
№1 / 2023
|
|
Osadchaya O.A., Eroshkin P.V., Kirichenko A.A., Lapovok I.A., Saleeva D.V., Lopatukhin A.E., Shlykova A.V., Kireev D.E., Grigoryan T.R., Petrosyan A.R., Sarhatyan T.F., Pokrovsky V.V.
Studying the transmission of HIV-1 drug resistance in the Republic of Armenia using bioinformatics methods
|
№4 / 2021
|
|
Orlova-Morozova E.A., Pronin A.Yu.
The use of doravirine as part of antiretroviral therapy regimens in patients with resistance mutations
|
№3 / 2021
|
|
Kirichenko A.A., Kireev D.E., Shlykova A.V., Lopatukhin A.E., Lapovok I.A., Saleeva D.V., Kravchenko A.V., Pokrovsky V.V.
HIV-1 drug resistance in patients with virological inefficiency on ART in Russia in 2013–2021
|
№3 / 2021
|
|
Degtyareva S.Yu., Zimina V.N., Pokrovskaya А.V., Konovalova A.A., Volchenkov G.V.
The spectrum of adverse events in the treatment of multidrug-resistant tuberculosis among people receiving antiretroviral therapy
|
№2 / 2021
|
|
Kravchenko A.V., Kanestri V.G.
The problem of body weight gain in HIV-infected patients during antiretroviral therapy
|
№3 / 2020
|
|
Provorova V.V., Krasnova E.I., Khokhlova N.I., Kuimova I.V., Izvekova I.Ya.
Influenza in the HIV infected
|
№2 / 2019
|
Русский
